## Note
nid: 1577423158694
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::2obgyn, #AK_Step2_v11::!Shelf::ObGyn::no_dupes, #AK_Step2_v11::!Shelf::ObGyn::no_dupes::only_step2, #AK_Step2_v11::#OME_banner::Basic_Science::03_Genetics, #AK_Step2_v11::#Resources_by_rotation::ObGyn::uw::dorian, #AK_Step2_v11::#Subjects::Microbiology::01_Bacteria::STIs::Chlamydia_vs_Neisseria::Management, #AK_Step2_v11::$AnKingUpdates::$Errata::v11, #AK_Step2_v11::Original_decks::Dorian::obgyn::uw
markdown: false

### Text
What do current guidelines recommend in the treatment against
<b>gonococcal infections</b>?
<div>
  {{c1::Ceftriaxone}}
</div>

### Extra
CDC recommends ceftriaxone monotherapy for treatment because <i>N.
gonorrhoeae</i> remains highly susceptible to ceftriaxone,
azithromycin resistance is increasing, and prudent use of
antimicrobial agents supports limiting their use.

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org/spa/obgyn?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_1.png"></a>
</div>

### Additional Resources
<a href=
"https://www.cdc.gov/mmwr/volumes/69/wr/mm6950a6.htm">https://www.cdc.gov/mmwr/volumes/69/wr/mm6950a6.htm</a>
"This update provides the rationale for the change in gonorrhea
treatment recommendations to a higher dose (500 mg) of ceftriaxone
and removal of azithromycin from the recommended regimen."

### One by one

